Terms ending in 2036
Every in-force patent on Biodesix, Inc.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,779,204 | Predictive Test for Aggressiveness or Indolence of Prostate Cancer from Mass Spectrometry of Blood-Based Sample In force · High confidence | Biodesix Inc. | In force | High confidence | |
| US 10,489,550 | Predictive Test for Aggressiveness or Indolence of Prostate Cancer from Mass Spectrometry of Blood-Based Sample In force · High confidence | Biodesix Inc. | In force | High confidence | |
| US 10,007,766 | Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods In force · High confidence | H. Lee Moffitt Cancer Center and Research Institute, Inc. | In force | High confidence | |
| US 12,230,398 | Predictive Test for Patient Benefit from Antibody Drug Blocking Ligand Activation of the T-Cell Programmed Cell Death 1 (PD-1) Checkpoint Protein and Classifier Development Methods In force · High confidence | Biodesix, Inc. | In force | High confidence | |
| US 10,037,874 | Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF Mass Spectrometry In force · High confidence | The Board of Regents of the University of Texas System | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Biodesix, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.